Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.42
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
51
52
Next >
Counterfeit Ozempic Raises Alarms - Lebanon Reports Hypoglycemia Cases
November 29, 2023
Lebanese health officials have reported eleven cases of severe hypoglycemia linked to suspected fake versions of Novo Nordisk A/S's (NYSE: NVO)
Via
Benzinga
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
November 29, 2023
Real-world data showed some real-world advantages for Ozempic's top rival.
Via
The Motley Fool
Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives
November 28, 2023
The study examined health care records for more than 41,000 people.
Via
Investor's Business Daily
Eli Lilly's Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk's Ozempic In Real World Study
November 28, 2023
A recent extensive analysis by Truveta Research has
Via
Benzinga
Only Have $100? 3 No-Brainer Stocks to Buy Right Now
November 28, 2023
The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks.
Via
InvestorPlace
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments
November 27, 2023
Novo Nordisk A/S (NYSE: NVO) is reportedly discussing with healthcare systems to introduce innovative pricing arrangements for its popular weight
Via
Benzinga
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
November 24, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
November 22, 2023
Via
Benzinga
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
November 26, 2023
An upcoming mid-stage readout may not spark a trend reversal in the big pharma's shares.
Via
The Motley Fool
Google Leads Five S&P 500 Stocks Near Buy Points
November 25, 2023
Four of the stocks tripped up after earnings, but quickly bounced back.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Could Ozempic Harm These 3 Medical Device Stocks?
November 25, 2023
The drug is on track to cause massive competitive shifts in the healthcare sector.
Via
The Motley Fool
Novo Nordisk's Wegovy Eyes Asian Market Debut Despite Supply Crunch
November 24, 2023
Novo Nordisk A/S (NYSE: NVO) reportedly plans to introduce its highly sought-after anti-obesity medication, Wegovy, in Japan on February 22, marking its inaugural entry into the Asian market despite...
Via
Benzinga
7 Stocks Set to Capitalize on the Coming Year-End Rally
November 24, 2023
The stock market is poised to rally at the year end as multiple positive factors conspire to push certain sectors higher.
Via
InvestorPlace
Peering Into Novo Nordisk's Recent Short Interest
November 22, 2023
Via
Benzinga
This Is What Whales Are Betting On Novo Nordisk
November 20, 2023
Via
Benzinga
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) Technical Analysis observations.
November 20, 2023
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Via
Chartmill
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
November 23, 2023
Plug into a trio of megatrends with these three particular tickers.
Via
The Motley Fool
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
November 23, 2023
This initiative has been touted as the biggest investment in the health sector ever made during Macron's tenure.
Via
Benzinga
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
November 22, 2023
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.
Via
InvestorPlace
Ozempic's Surging Demand Has Novo Nordisk Restricting It In Europe, Plus An Older Generation Diabetes Drug: What's Next?
November 21, 2023
Novo Nordisk A/S (NYSE: NVO) plans to limit starter kit supplies of Ozempic (semaglutide) in Europe and reduce the distribution of Victoza (liraglutide), aiming to bolster Ozempic's production, which...
Via
Benzinga
3 Consumer Goods Stocks That Will Define the Next Decade
November 21, 2023
These companies can be expected to continue shaping our lives for the foreseeable future thanks to their strong brands.
Via
InvestorPlace
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
November 21, 2023
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...
Via
Benzinga
Topics
ETFs
Don't overlook NYSE:NVO—a stock with solid growth prospects and a reasonable valuation.
November 21, 2023
While growth is established for NYSE:NVO, the stock's valuation remains reasonable.
Via
Chartmill
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
November 20, 2023
New medicines for weight loss and diabetes stand to disrupt the competitive scene.
Via
The Motley Fool
3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist
November 20, 2023
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry-leading stocks that billionaire investors can't stop buying.
Via
The Motley Fool
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
November 19, 2023
Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.
Via
The Motley Fool
Exposures
Product Safety
GE, Amazon Lead 5 Stocks Near Buy Points With This Bullish Trait
November 18, 2023
Relative strength is key when choosing top stocks. GE, Amazon meet RS Line Blue Dot screen.
Via
Investor's Business Daily
AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the Stock
November 17, 2023
It might have a hard time finding a home in the market.
Via
The Motley Fool
7 A-Rated Retirement Stocks for Your November Buy List
November 17, 2023
These A-rated retirement stocks represent companies that are stable, reliable, and well-suited for long-term investors.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
Pharmaceutical Giant Eli Lilly Plans Expansion In Germany, Eyes Diabetes Drug Production: Report
November 16, 2023
Eli Lilly And Co (NYSE: LLY) reportedly intends to construct a production plant in western Germany with an estimated investment of €2 billion ($2.17 billion), marking an inaugural substantial...
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.